Kezic, Aleksandra <br/><br/>
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?  [electronic resource] 

 -  Oxidative medicine and cellular longevity  2018 
 - 2640342 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1942-0994 
<br/><br/><label>Standard No.: </label>10.1155/2018/2640342  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Animals<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Glucose--metabolism<br/>Humans<br/>Metformin--therapeutic use<br/>TOR Serine-Threonine Kinases--metabolism